{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:06:14Z","timestamp":1785787574342,"version":"3.56.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pregnant individuals have been historically excluded from clinical trials. To evaluate the safety of vaccines in pregnant individuals and their infants, more data on expected ranges of background rates of pregnancy-related outcomes of interest are needed. The objective of this real-world observational study was to assess background rates of maternal, pregnancy and neonatal\/infant outcomes in pregnant individuals and their infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective observational cohort study of pregnant individuals and their infants using data from Kaiser Permanente Northern California from January 1, 2007, to December 31, 2018. We assessed the incidence proportions of 17 maternal, 4 pregnancy and 10 neonatal\/infant outcomes of interest, including eclampsia, preterm labor and stillbirths. Incidence proportions were stratified by maternal age group, race\/ethnicity and insurance type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 415,074 singleton pregnancies and 413,488 singleton live births included in the study. The most common adverse outcomes (&gt;10%) were preterm labor, gestational diabetes, minor congenital anomalies, macrosomia and large for gestational age. The proportions for pregnancy-related hypertension, fetal asphyxia and preeclampsia were also relatively high (between 5% and 7%). Pregnant individuals (and their infants) in the youngest and oldest age groups, and those of Black race, had the highest proportions for nearly all outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Overall, the proportions of the outcomes assessed were generally consistent with previously published literature of pregnant individuals and their infants in the United States (US). The study provides background rates of important maternal, pregnancy and neonatal\/infant outcomes in a US population that may inform vaccine clinical trials and vaccine safety studies in pregnant individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004639","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:02:09Z","timestamp":1739534529000},"page":"S130-S134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Informing Maternal Immunization Trials: An Observational Study to Assess Background Rates of Maternal, Pregnancy, and Neonatal\/Infant Outcomes"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-0886","authenticated-orcid":false,"given":"Amber","family":"Hsiao","sequence":"first","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-6215","authenticated-orcid":false,"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7891-2673","authenticated-orcid":false,"given":"John","family":"Hansen","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Timbol","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned","family":"Lewis","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-7877","authenticated-orcid":false,"given":"Se","family":"Li","sequence":"additional","affiliation":[{"name":"GSK, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5259-8183","authenticated-orcid":false,"given":"Wenji","family":"Pu","sequence":"additional","affiliation":[{"name":"GSK, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-6214","authenticated-orcid":false,"given":"Antonella N.","family":"Tullio","sequence":"additional","affiliation":[{"name":"GSK, Rockville, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-4814","authenticated-orcid":false,"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Vaccine Study Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/07853890.2017.1421320","article-title":"Maternal immunization: where are we now and how to move forward?","volume":"50","author":"Vojtek","year":"2018","journal-title":"Ann Med"},{"key":"R2-20260413","article-title":"Vaccines During and After Pregnancy."},{"key":"R3-20260413","first-page":"461","article-title":"Vaccines against influenza WHO position paper \u2013 November 2012.","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"R4-20260413","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - September 2015.","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"R5-20260413","first-page":"53","article-title":"Tetanus vaccines: WHO position paper \u2013 February 2017.","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"R6-20260413","article-title":"COVID-19 Vaccines While Pregnant or Breastfeeding."},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/21645515.2015.1127485","article-title":"Vaccines in pregnancy: the dual benefit for pregnant women and infants.","volume":"12","author":"Marshall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000001150","article-title":"ACOG Committee Opinion No. 646: Ethical Considerations for Including Women as Research Participants.","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","article-title":"Maternal vaccination: a review of current evidence and recommendations.","volume":"226","author":"Etti","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20260413","article-title":"Adacel."},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40121-022-00731-8","article-title":"Investigating tetanus, diphtheria, acellular pertussis vaccination during pregnancy and risk of congenital anomalies.","volume":"12","author":"Florea","year":"2023","journal-title":"Infect Dis Ther"},{"key":"R14-20260413","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1016\/j.vaccine.2022.06.009","article-title":"Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.","volume":"40","author":"Tseng","year":"2022","journal-title":"Vaccine"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.2018.17716","article-title":"Increasing the participation of pregnant women in clinical trials.","volume":"320","author":"Heyrana","year":"2018","journal-title":"JAMA"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy - the GAIA project.","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"},{"key":"R18-20260413","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1186\/s12913-018-3732-3","article-title":"Standardized outcome measures for pregnancy and childbirth, an ICHOM proposal.","volume":"18","author":"Nijagal","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"R19-20260413","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1016\/j.vaccine.2016.10.006","article-title":"Kaiser Permanente Northern California pregnancy database: description and proof of concept study.","volume":"34","author":"Zerbo","year":"2016","journal-title":"Vaccine"},{"key":"R20-20260413","doi-asserted-by":"crossref","first-page":"e2018741","DOI":"10.1001\/jamanetworkopen.2020.18741","article-title":"Evaluation of US state-level variation in hypertensive disorders of pregnancy.","volume":"3","author":"Butwick","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R21-20260413","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jama.2019.9818","article-title":"Incidence of maternal sepsis and sepsis-related maternal deaths in the United States.","volume":"322","author":"Hensley","year":"2019","journal-title":"JAMA"},{"key":"R22-20260413","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.12659\/MSM.907723","article-title":"Liver disease during pregnancy: a challenging clinical issue.","volume":"24","author":"Mikolasevic","year":"2018","journal-title":"Med Sci Monit"},{"key":"R23-20260413","doi-asserted-by":"crossref","first-page":"330","DOI":"10.14366\/usg.18006","article-title":"The impact of first-trimester intrauterine hematoma on adverse perinatal outcomes.","volume":"37","author":"Peixoto","year":"2018","journal-title":"Ultrasonography"},{"key":"R24-20260413","doi-asserted-by":"crossref","first-page":"e28343","DOI":"10.1371\/journal.pone.0028343","article-title":"Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort.","volume":"7","author":"Rook","year":"2012","journal-title":"PLoS One"},{"key":"R25-20260413","first-page":"13841393","article-title":"Intrauterine growth retardation.","volume":"58","author":"Vandenbosche","year":"1998","journal-title":"Am Fam Physician"},{"key":"R26-20260413","first-page":"1","article-title":"Fetal mortality: United States, 2019.","volume":"70","author":"Gregory","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"R27-20260413","first-page":"1","article-title":"Fetal mortality: United States, 2020.","volume":"71","author":"Gregory","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"R28-20260413","first-page":"1","article-title":"Describing the increase in preterm births in the United States, 2014-2016.","volume":"312","author":"Martin","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R29-20260413","first-page":"1","article-title":"Infant mortality by age at death in the United States, 2016.","volume":"326","author":"Ely","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R30-20260413","first-page":"1","article-title":"Singleton low birthweight rates, by race and Hispanic origin: United States, 2006-2016.","volume":"306","author":"Womack","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R31-20260413","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1542\/peds.2004-0708","article-title":"Declining diagnosis of birth asphyxia in California: 1991\u20132000.","volume":"114","author":"Wu","year":"2004","journal-title":"Pediatrics"},{"key":"R32-20260413","article-title":"Birth defects: Epidemiology, types, and patterns.","author":"Bacino"},{"key":"R33-20260413","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010-2014.","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res"},{"key":"R34-20260413","first-page":"1","article-title":"Trends and characteristics in gestational diabetes: United States, 2016-2020.","volume":"71","author":"Gregory","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"R35-20260413","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s10995-014-1624-7","article-title":"Maternal age and risk of labor and delivery complications.","volume":"19","author":"Cavazos-Rehg","year":"2015","journal-title":"Matern Child Health J"},{"key":"R36-20260413","doi-asserted-by":"crossref","first-page":"e033697","DOI":"10.1136\/bmjopen-2019-033697","article-title":"Variation in relationships between maternal age at first birth and pregnancy outcomes by maternal race: a population-based cohort study in the United States.","volume":"9","author":"Schummers","year":"2019","journal-title":"BMJ Open"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:12:14Z","timestamp":1785784334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000004639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":33,"journal-issue":{"issue":"2S","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004639","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}